[논문]General and Genetic Toxicology of Enzyme-Treated Ginseng Extract - Toxicology of Ginseng Rh2+ -

Jeong, Mi-Kyung; Cho, Chong-Kwan; Yoo, Hwa-Seung

doi:10.3831/kpi.2016.19.022

General and Genetic Toxicology of Enzyme-Treated Ginseng Extract - Toxicology of Ginseng Rh2+ - 원문보기

Journal of pharmacopuncture, v.19 no.3, 2016년, pp.213 - 224

Jeong, Mi-Kyung (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University) , Cho, Chong-Kwan (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University) , Yoo, Hwa-Seung (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University)

Abstract ▼ AI-Helper

Objectives: Ginseng Rh2+ is enzyme-treated ginseng extract containing high amounts of converted ginsenosides, such as compound k, Rh2, Rg3, which have potent anticancer activity. We conducted general and genetic toxicity tests to evaluate the safety of ginseng Rh2+. Methods: An acute oral toxicity test was performed at a high-level dose of 4,000 mg/kg/day in Sprague-Dawley (SD) rats. A 14-day range-finding study was also conducted to set dose levels for the 90-day study. A subchronic 90-day toxicity study was performed at dose levels of 1,000 and 2,000 mg/kg/day to investigate the no-observed-adverse-effect level (NOAEL) of ginseng Rh2+ and target organs. To identify the mutagenic potential of ginseng Rh2+, we conducted a bacterial reverse mutation test (Ames test) using amino-acid-requiring strains of Salmonella typhimurium and Escherichia coli (E. coli), a chromosome aberration test with Chinese hamster lung (CHL) cells, and an in vivo micronucleus test using ICR mice bone marrow as recommended by the Korean Ministry of Food and Drug Safety. Results: According to the results of the acute oral toxicity study, the approximate lethal dose (ALD) of ginseng Rh2+ was estimated to be higher than 4,000 mg/kg. For the 90-day study, no toxicological effect of ginseng Rh2+ was observed in body-weight changes, food consumption, clinical signs, organ weights, histopathology, ophthalmology, and clinical pathology. The NOAEL of ginseng Rh2+ was established to be 2,000 mg/kg/day, and no target organ was found in this test. In addition, no evidence of mutagenicity was found either on the in vitro genotoxicity tests, including the Ames test and the chromosome aberration test, or on the in vivo in mice bone marrow micronucleus test. Conclusion: On the basis of our findings, ginseng Rh2+ is a non-toxic material with no genotoxicity. We expect that ginseng Rh2+ may be used as a novel adjuvant anticancer agent that is safe for long-term administration.

주제어

참고문헌 (41)

1 Jia L Zhao Y Current evaluation of the millennium phytomedicine--ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations Curr Med Chem 2009 16 19 2475 2484 10.2174/092986709788682146 19601793

상세보기
2 Christensen LP Ginsenosides chemistry, biosynthesis, analysis, and potential health effects Adv Food Nutr Res 2009 55 1 99 18772102
3 Qi LW Wang CZ Yuan CS Isolation and analysis of ginseng: advances and challenges Nat Prod Rep 2011 28 3 467 495 10.1039/c0np00057d 21258738

상세보기
4 Shin BK Kwon SW Park JH Chemical diversity of ginseng saponins from Panax ginseng J Ginseng Res 2015 39 4 287 298 10.1016/j.jgr.2014.12.005 26869820

원문보기 상세보기
5 Wang W Zhao Y Rayburn ER Hill DL Wang H Zhang R In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng Cancer Chemother Pharmacol 2007 59 5 589 601 10.1007/s00280-006-0300-z 16924497

상세보기
6 Wang CZ Du GJ Zhang Z Wen XD Calway T Zhen Z et al Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer Int J Oncol 2012 40 6 1970 1976 22426808

상세보기
7 Shibata S Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds J Korean Med Sci 2001 S16 S28 37 10.3346/jkms.2001.16.S.S28 11748374

상세보기
8 Jang SI Lee YW Cho CK Yoo HS Jang JH Identification of target genes involved in the antiproliferative effect of enzyme-modified ginseng extract in HepG2 hepatocarcinoma cell Evid Based Complement Alternat Med 2013 2013 ID502568

상세보기
9 Kim KH Choi I Lee YW Cho CK Yoo HS Lee SB et al Target genes involved in antiproliferative effect of modified ginseng extracts in lung cancer A549 cells Acta Biochim Biophys Sin (Shanghai) 2014 46 6 441 449 10.1093/abbs/gmu025 24742432

상세보기
10 Hwang JW Baek YM Jang IS Yang KE Lee DG Yoon SJ et al An enzymatically fortified ginseng extract inhibits proliferation and induces apoptosis of KATO3 human gastric cancer cells via modulation of Bax, mTOR, PKB and IκBα Mol Med Rep 2015 11 1 670 676 25333578
11 Chan PC Peckham JC Malarkey DE Kissling GE Travlos GS Fu PP Two-year toxicity and carcinogenicity studies of Panax ginseng in fischer 344 rats and B6C3F1 mice Am J Chin Med 2011 39 4 779 788 21721156

상세보기
12 Seely D Dugoua JJ Perri D Mills E Koren G Safety and efficacy of Panax ginseng during pregnancy and lactation Can J Clin Pharmacol 2008 15 1 e87 94 18204104
13 Park SJ Lim KH Noh JH Jeong EJ Kim YS Han BC et al Subacute oral toxicity study of Korean red ginseng extract in sprague-dawley rats Toxicol Res 2013 29 4 285 292 10.5487/TR.2013.29.4.285 24578799

원문보기 상세보기
14 Schmid W The micronucleus test Mutat Res 1975 31 1 9 15 10.1016/0165-1161(75)90058-8 48190

상세보기
15 Tawab MA Bahr U Karas M Wurglics M Schubert- Zsilavecz M Degradation of ginsenosides in humans after oral administration Drug Metab Dispos 2003 31 8 1065 1071 10.1124/dmd.31.8.1065 12867496

상세보기
16 Hasegawa H Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid J Pharmacol Sci 2004 95 2 153 157 10.1254/jphs.FMJ04001X4 15215638

상세보기
17 Lee SJ Kim YJ Kim MG Changes in the ginsenoside content during the fermentation process using microbial strains J Ginseng Res 2015 39 4 392 397 10.1016/j.jgr.2015.05.005 26869833

원문보기 상세보기
18 Quan LH Kim YJ Li GH Choi KT Yang DC Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius World J Microbiol Biotechnol 2013 29 6 1001 1007 10.1007/s11274-013-1260-1 23338962

상세보기
19 Cho SH Chung KS Choi JH Kim DH Lee KT Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells BMC Cancer 2009 9 449 20017956

상세보기
20 Zheng ZZ Ming YL Chen LH Zheng GH Liu SS Chen QX Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro Oncol Rep 2014 32 1 325 331 10.3892/or.2014.3171 24804620

상세보기
21 Kim AD Kang KA Kim HS Kim DH Choi YH Lee SJ et al A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells Cell Death Dis 2013 4 e750

상세보기
22 Hu C Song G Zhang B Liu Z Chen R Zhang H et al Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway J Cell Mol Med 2012 16 1 96 106 10.1111/j.1582-4934.2011.01278.x 21323864

상세보기
23 Kang KA Piao MJ Kim KC Zheng J Yao CW Cha JW et al Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity Int J Oncol 2013 43 6 1907 1914 24100442

상세보기
24 Zhang Z Du GJ Wang CZ Wen XD Calway T Li Z et al Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions Int J Mol Sci 2013 14 2 2980 2995 10.3390/ijms14022980 23434653

상세보기
25 Wang CZ Cai Y Anderson S Yuan CS Ginseng metabolites on cancer chemoprevention: an angiogenesis link? Diseases 2015 3 3 193 204 10.3390/diseases3030193 26941993

상세보기
26 Yang Z Zhao T Liu H Zhang L Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy Sci Rep 2016 6 19383 26783250

상세보기
27 Tang XP Tang GD Fang CY Liang ZH Zhang LY Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells World J Gastroenterol 2013 19 10 1582 1592 10.3748/wjg.v19.i10.1582 23538603

상세보기
28 Choi S Kim TW Singh SV Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases Pharm Res 2009 26 10 2280 2288 10.1007/s11095-009-9944-9 19629651

상세보기
29 Yoon JH Choi YJ Lee SG Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells Eur J Pharmacol 2012 679 1-3 24 33 10.1016/j.ejphar.2012.01.020 22314224

상세보기
30 Jung JS Ahn JH Le TK Kim DH Kim HS Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells Neurochem Int 2013 63 2 80 86 10.1016/j.neuint.2013.05.002 23684955

상세보기
31 Test No. 471: Bacterial Reverse Mutation Test OECD France 1997 Available from: http://www.oecd-ilibrary.org/environment/test-no-471-bacterialreverse-mutation-test_9789264071247-en.
32 Chen Q Tang S Jin X Zou J Chen K Zhang T et al Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells Food Chem Toxicol 2009 47 2 328 334 10.1016/j.fct.2008.11.020 19061932

상세보기
33 Scheutwinkel-Reich M vd Hude W Sister-chromatid exchange in Chinese hamster V79 cells exposed to quindoxin, carbadox and olaquindox Mutat Res 1984 139 4 199 202 10.1016/0165-7992(84)90128-3 6717485

상세보기
34 Test No. 408: Repeated Dose 90-day Oral Toxicity Study in Rodents OECD France 1998 Available from: http://www.oecd-ilibrary.org/environment/testno-408-repeated-dose-90-day-oral-toxicity-study-inrodents_9789264070707-en.
35 Jena GB Kaul CL Poduri R Genotoxicity testing, a regulatory requirement for drug discovery and development: impact of ICH guidelines Indian J Pharm 2002 34 86 99
36 Hesketh PJ Chemotherapy-induced nausea and vomiting N Engl J Med 2008 358 23 2482 2494 10.1056/NEJMra0706547 18525044

상세보기
37 Shumay DM Maskarinec G Kakai H Gotay CC Why some cancer patients choose complementary and alternative medicine instead of conventional treatment J Fam Pract 2001 50 12 1067 11742609

상세보기
38 Tian JH Liu LS Shi ZM Zhou ZY Wang L A randomized controlled pilot trial of "Feiji Recipe" on quality of life of non-small cell lung cancer patients Am J Chin Med 2010 38 1 15 25 20128041

상세보기
39 Wang CZ Calway T Yuan CS Herbal medicines as adjuvants for cancer therapeutics Am J Chin Med 2012 40 4 657 669 10.1142/S0192415X12500498 22809022

상세보기
40 Li Y Zhou T Ma C Song W Zhang J Yu Z Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells J Thorac Dis 2015 7 3 400 406 25922718

상세보기
41 Zhang K Li Y Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer Pharm Biol 2016 54 4 561 568 10.3109/13880209.2015.1101142 26511312

상세보기

저자의 다른 논문 :

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증